The effect of CPAP withdrawal on blood pressure in OSA: Data from three randomised-controlled trials

E. I. Schwarz, C. Schlatzer, V. A. Rossi, C. Nowak, K. E. Bloch, J. R. Stradling, M. Kohler (Zurich, Switzerland; Oxford, United Kingdom)

Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Session: The story continues: impact of OSA on cardiometabolic parameters
Session type: Poster Discussion
Number: 1740
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Abstract

BackgroundBased on meta-analyses, the blood pressure (BP) lowering effect of continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA) is reported to be 2mmHg. This figure is derived from trials often limited by poor CPAP compliance, thus, underestimating the effect of CPAP treatment. We analysed BP data from randomised-controlled CPAP withdrawal trials which included only optimally CPAP compliant patients.Methods145 OSA patients on CPAP were randomised to continue therapeutic (n=62) or to withdraw CPAP (n=83) for two weeks. Morning BP was measured at home before and in hospital after sleep studies.ResultsCPAP withdrawal was associated with a return of OSA (apnoea-hypopnoea index (AHI) at baseline 2.8/h, at follow-up 33.2/h). Systolic office BP increased in the CPAP withdrawal group compared to CPAP continuation by +6.5mmHg (95%CI 2.6-10.4mmHg, p=0.001) and systolic home BP by +9.7mmHg (95%-CI 6.3-13.0mmHg, p<0.001); diastolic office BP increased by +5.0mmHg (95%CI 2.4-7.6mmHg, p<0.001) and diastolic home BP by +7.9mmHg (95%CI 5.6-10.3mmHg, p<0.001).AHI, baseline systolic BP, statins, gender and number of antihypertensive drugs were independently associated with systolic BP change in multivariate analysis controlled for age, BMI, smoking, diabetes, and sleepiness. Change in diastolic BP was independently predicted by AHI, baseline diastolic BP, and statins.ConclusionsShort-term CPAP withdrawal results in a clinically relevant increase in BP, which is considerably higher than in conventional CPAP trials and may be underestimated if only office BP values are used. OSA severity and baseline BP seem to be predictors of BP response to CPAP.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. I. Schwarz, C. Schlatzer, V. A. Rossi, C. Nowak, K. E. Bloch, J. R. Stradling, M. Kohler (Zurich, Switzerland; Oxford, United Kingdom). The effect of CPAP withdrawal on blood pressure in OSA: Data from three randomised-controlled trials. Eur Respir J 2014; 44: Suppl. 58, 1740

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The micro-RNA hsa-miR-502-3p is down-regulated in the plasma of obstructive sleep apnea patients after 2 weeks of continuous positive airway pressure therapy withdrawal: Data from a randomized controlled trial
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



Autoregulation versus defaecation: An unusual side effect of CPAP
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


The effect of positive airway pressure on cholesterol in patients with sleep apnea: Data from the European Sleep Apnea Network (ESADA)
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Effect of continuous positive airway pressure on blood pressure and the metabolic profile of women with obstructive sleep apnoea. A randomized-controlled trial
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016



A case series of CPAP therapy – Who declines treatment?
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

A randomized controlled trial of auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ)
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016

Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Adherence to continuous positive airway pressure therapy (CPAP) in patients with obstructive sleep apnea (OSA) in an Asian privately funded healthcare system
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Sleep quality and duration in patients with chronic heart failure and sleep disordered breathing
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Evaluation of the apnea-hypopnea index determined by adaptive-servo ventilation devices in heart failure patients with sleep disordered breathing
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014


Impact of continuous positive airway pressure on liver injury induced by obstructive sleep apnea: Data from randomized controlled trials
Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing
Year: 2015


Oscillating positive airway pressure (O-PAP) vs CPAP treatment in patients with obstructive sleep apneas
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014

Continuous positive airway pressure (CPAP) supported by telemedicine improves sleepiness and quality of life but not blood pressure in high cardiovascular risk obstructive sleep apnea (OSA): A randomized, controlled trial
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013


Predictors of titrating pressure using A-CPAP in obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


Prediction of therapeutic effectiveness of nocturnal oxygen supplementation in Cheyne-Stokes breathing
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014

The effect of continuous positive airway pressure therapy on endothelial function in obstructive sleep apnea: A systematic review and meta-analysis
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014

The effect of CPAP on blood pressure in patients with OSAS and resistant hypertension followed 1 year
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015